Latest Publications
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models
Shukla, G.S., S.C. Pero, Y. Sun, L. Mei, F. Zhang, G. Sholler, and D.N. Krag, Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models. Clin Transl Oncol,[...]
Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients
Izhar S. Batth, Long Dao, Arun Satelli, Abhisek Mitra, Sofia Yi, Hyangsoon Noh, Heming Li, Zachary, Brownlee, Shouhao Zhou, Jeffrey Bond, Jing Wang, Jonathan Gill, Giselle S. Sholler, Shulin Li, Cell surface vimentin-positive circulating tumor cell-based[...]
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis, Jacqueline M. Kraveka, William Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Peter Zage, Jawhar Rawwas, Maria Rich, Elizabeth Lorenzi, Kristine[...]
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen Neville, Don Eslin, Valerie Brown, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Nehal S. Parikh, Francis Eshun, Peter Zage,[...]
Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses
Shukla GS, Sun YJ, Pero SC, Sholler GS, Krag DN. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses. J Immunol Methods. 2018 Sep;460:51-62
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WP, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS, Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma, Front. Pharmacol.,[...]
In The Press
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
On-Going Research
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.